IBDEI1ZZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31874,1,3,0)
 ;;=3^Antenatal Screening,Unspec
 ;;^UTILITY(U,$J,358.3,31874,1,4,0)
 ;;=4^Z36.9
 ;;^UTILITY(U,$J,358.3,31874,2)
 ;;=^5151856
 ;;^UTILITY(U,$J,358.3,31875,0)
 ;;=Z36.83^^126^1633^19
 ;;^UTILITY(U,$J,358.3,31875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31875,1,3,0)
 ;;=3^Fetal Screening for Cogenital Cardia Abnormality
 ;;^UTILITY(U,$J,358.3,31875,1,4,0)
 ;;=4^Z36.83
 ;;^UTILITY(U,$J,358.3,31875,2)
 ;;=^5151848
 ;;^UTILITY(U,$J,358.3,31876,0)
 ;;=Z36.2^^126^1633^6
 ;;^UTILITY(U,$J,358.3,31876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31876,1,3,0)
 ;;=3^Antenatal Screening for Follow-up,Other
 ;;^UTILITY(U,$J,358.3,31876,1,4,0)
 ;;=4^Z36.2
 ;;^UTILITY(U,$J,358.3,31876,2)
 ;;=^5151842
 ;;^UTILITY(U,$J,358.3,31877,0)
 ;;=Z36.89^^126^1633^15
 ;;^UTILITY(U,$J,358.3,31877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31877,1,3,0)
 ;;=3^Antenatal Screening,Other Specified
 ;;^UTILITY(U,$J,358.3,31877,1,4,0)
 ;;=4^Z36.89
 ;;^UTILITY(U,$J,358.3,31877,2)
 ;;=^5151854
 ;;^UTILITY(U,$J,358.3,31878,0)
 ;;=N39.0^^126^1634^57
 ;;^UTILITY(U,$J,358.3,31878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31878,1,3,0)
 ;;=3^Urinary tract infection, site not specified
 ;;^UTILITY(U,$J,358.3,31878,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,31878,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,31879,0)
 ;;=R31.9^^126^1634^23
 ;;^UTILITY(U,$J,358.3,31879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31879,1,3,0)
 ;;=3^Hematuria, unspecified
 ;;^UTILITY(U,$J,358.3,31879,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,31879,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,31880,0)
 ;;=R31.0^^126^1634^22
 ;;^UTILITY(U,$J,358.3,31880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31880,1,3,0)
 ;;=3^Gross hematuria
 ;;^UTILITY(U,$J,358.3,31880,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,31880,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,31881,0)
 ;;=N39.3^^126^1634^45
 ;;^UTILITY(U,$J,358.3,31881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31881,1,3,0)
 ;;=3^Stress incontinence (female) (male)
 ;;^UTILITY(U,$J,358.3,31881,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,31881,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,31882,0)
 ;;=N39.41^^126^1634^54
 ;;^UTILITY(U,$J,358.3,31882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31882,1,3,0)
 ;;=3^Urge incontinence
 ;;^UTILITY(U,$J,358.3,31882,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,31882,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,31883,0)
 ;;=N39.46^^126^1634^28
 ;;^UTILITY(U,$J,358.3,31883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31883,1,3,0)
 ;;=3^Mixed incontinence
 ;;^UTILITY(U,$J,358.3,31883,1,4,0)
 ;;=4^N39.46
 ;;^UTILITY(U,$J,358.3,31883,2)
 ;;=^5015685
 ;;^UTILITY(U,$J,358.3,31884,0)
 ;;=Z90.79^^126^1634^5
 ;;^UTILITY(U,$J,358.3,31884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31884,1,3,0)
 ;;=3^Acquired Absence of Oth Genital Organ(s)
 ;;^UTILITY(U,$J,358.3,31884,1,4,0)
 ;;=4^Z90.79
 ;;^UTILITY(U,$J,358.3,31884,2)
 ;;=^5063596
 ;;^UTILITY(U,$J,358.3,31885,0)
 ;;=N91.2^^126^1634^6
 ;;^UTILITY(U,$J,358.3,31885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31885,1,3,0)
 ;;=3^Amenorrhea,Unspec
 ;;^UTILITY(U,$J,358.3,31885,1,4,0)
 ;;=4^N91.2
 ;;^UTILITY(U,$J,358.3,31885,2)
 ;;=^5015904
 ;;^UTILITY(U,$J,358.3,31886,0)
 ;;=N30.10^^126^1634^14
 ;;^UTILITY(U,$J,358.3,31886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31886,1,3,0)
 ;;=3^Cystitis,Interstitial w/o Hematuria
